This publication is under review (Sept 2019). Guidance for rheumatology specialist practitioners and the wider health care team on assessing, managing and monitoring biologic therapies for inflammatory arthritis.
This is the third edition of the RCN’s guidance and has been updated to ensure the publication contains the latest evidence-based guidance to support practitioners in the safe and confident administration of subcutaneous methotrexate in a variety of primary and secondary care settings, including community and managed care environments. The guidance covers aspects of both adult and children/young people’s care.
Publication providing a snapshot of rheumatology nursing services in the UK and identifies the scope and breadth of nursing activity, while enabling nurses to compare their skills and competences against other specialists in their field of practice.
Page last updated - 05/03/2019